Cytokinetics SG&A Expense (Quarterly) Insights

Cytokinetics Inc (CYTK)

65.27 +0.93 (+1.45%) USD | NASDAQ | May 03, 16:00

65.33 +0.06 (+0.09%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2004. Upgrade now.

Date	Value
December 31, 2023	44.11M
September 30, 2023	40.11M
June 30, 2023	39.72M
March 31, 2023	49.66M
December 31, 2022	53.97M
September 30, 2022	48.22M
June 30, 2022	42.72M
March 31, 2022	33.07M
December 31, 2021	33.81M
September 30, 2021	26.20M
June 30, 2021	21.20M
March 31, 2021	15.60M
December 31, 2020	13.91M
September 30, 2020	12.30M
June 30, 2020	14.16M
March 31, 2020	12.45M
December 31, 2019	10.58M
September 30, 2019	9.753M
June 30, 2019	9.836M
March 31, 2019	9.437M
December 31, 2018	7.558M
September 30, 2018	7.164M
June 30, 2018	8.046M
March 31, 2018	9.264M
December 31, 2017	10.26M

Date	Value
September 30, 2017	9.657M
June 30, 2017	8.438M
March 31, 2017	8.115M
December 31, 2016	6.674M
September 30, 2016	7.217M
June 30, 2016	7.09M
March 31, 2016	6.841M
December 31, 2015	5.529M
September 30, 2015	5.276M
June 30, 2015	4.495M
March 31, 2015	4.367M
December 31, 2014	4.558M
September 30, 2014	3.993M
June 30, 2014	4.458M
March 31, 2014	4.259M
December 31, 2013	4.093M
September 30, 2013	3.635M
June 30, 2013	3.73M
March 31, 2013	3.634M
December 31, 2012	3.815M
September 30, 2012	2.991M
June 30, 2012	2.568M
March 31, 2012	3.056M
December 31, 2011	2.863M
September 30, 2011	3.204M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

9.753M

Minimum

Sep 2019

53.97M

Maximum

Dec 2022

27.97M

Average

26.20M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks